Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations

Author： Wisløff F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.16, Iss.4, 1999-10, pp. : 329-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermittent Claudication: Pharmacoeconomic and Quality-of-Life Aspects of Treatment

By Brevetti G.   Annecchini R.   Bucur R.  

PharmacoEconomics, Vol. 20, Iss. 3, 2002-01 ,pp. : 169-181

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Considerations in the Treatment of Multiple Sclerosis

By Sharac Jessica   McCrone Paul   Sabes-Figuera Ramon  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1677-1691

Adis International

Access to resources Recommend Favorite

Drug Treatment of Overactive Bladder: Efficacy, Cost and Quality-of-Life Considerations

By Hashim Hashim   Paul Abrams  

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1643-1656

Adis International

Access to resources Recommend Favorite

Quality-of-Life Considerations in the Treatment of Early-Stage Breast Cancer in the Elderly

By Reimer Toralf   Gerber Bernd  

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 791-800

Adis International

Access to resources Recommend Favorite

Therapeutic Options for the Prevention and Treatment of Postoperative Nausea and Vomiting: A Pharmacoeconomic Review

By Lachaine Jean  

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 955-970

Adis International

Access to resources Recommend Favorite